CHI3L1 and CHI3L2 expressions have been found to be significantly increased in the motor cortex of sporadic ALS patients compared with neurologically healthy controls, and their expression levels were correlated with the survival time from date of onset [14,108]. This evidence concerns the gene CHI3L1 and amyotrophic lateral sclerosis.